Chiklita ad

Showing posts with label Species. Show all posts
Showing posts with label Species. Show all posts

Saturday, 16 September 2017

Source of ageing process



Genes belong to a process called autophagy - this one of the cells most critical survival processes, it promotes health and fitness in young worms but drive the process of ageing later in life.

 Promoting longevity by closing down autophagy in old worms improves neuronal and subsequent whole body health. Getting old happens to every species, natural selection results in the fittest individuals for a given environment surviving to breed and pass on their genes to the next generation.

The more fruitful a trait is at promoting reproductive success, the stronger the selection for that trait will be. Some genes encourage ageing while still being essential for development, there are series of genes involved in regulating autophagy, which accelerate the ageing process.

The process of autophagy is a critical recycling process in the cell. Autophagy is known to become slower with age and closing it down in the initiation of the process allows the worms to live longer.

There are severe negative consequences when it breaks down and then you are better off bypassing it all together. In young worms, autophagy is working properly and is essential to reach maturity but after reproduction, it begins to malfunction causing the worms to age.

 By inactivating autophagy in the neurons of old worms they were able to prolong the worms life and increased the total health of the worms. Turning autophagy off only in one tissue and the whole animal gets a boost. The neurons are much healthier in the treated worms and keeps the muscles and the rest of the body in good shape.
          haleplushearty.blogspot.com

Saturday, 10 June 2017

Snake venom may replace aspiring for heart disease treatment


Snake venom may replace aspirin as a protein found in the poison of a species native to south-east Asia thins the blood without side effects.

The protein in snake venom slowed the rate of blood clot formation in mice. It
did not cause excessive bleeding, which is a common side effect of existing treatments.

Blood-thinning medications, also known as anti-platelet drugs, prevent specific blood cells from clumping together and forming clots.

Venom of the Tropidolaemus waglerix snake contains a protein, known as trowaglerix, that latches on to the receptor, called GPVI, to block its blood-clotting actions.

The protein was mixed with blood and given to mice. The result shows that the treated mice had slower blood clot formation than animals that did not receive the therapy.